INVESTIGADOR PRINCIPAL
Javier García Campayo

EQUIPO
Marta Mª Alda Díez, Angela Cristina Asensio Martínez, Nicolás Fayed Miguel, Santiago Gascón Santos, Jose Antonio Guallar Claver, Paola Herrera Mercadal, Lorena López Artal, Yolanda López Del Hoyo, Jesús Montero Marín, Carmen Montón Franco, Sergio Moreno González, Mª Teresa Navarro Gil, Bárbara Oliván Blázquez, Mª Cruz Pérez Yus, Marcelo Marcos Piva de Marzo, Marta Puebla Guedea, Miguel Angel Santed Germán.

Hospital Universitario Miguel Servet

• Prevención de la depresión
• Prevención, detección y manejo del Burnout
• Manejo de los pacientes somatizadores, fibromialgia e hiperfrecuentadores
• Psicopatología de la inmigración
• Economía de la salud e investigación en equidad
• Marcadores de vulnerabilidad genética y radiodiagnóstico

• Neurociencias y salud mental
• Atención Primaria

• Total artículos publicados con FI
• Artículos 1er y 2º cuartil
• Artículos 1er y 2º cuartil (ratio)
• Factor de Impacto
• Factor de Impacto medio
• Proyectos activos

• Garcia-Campayo J;Del Hoyo YL;Valero MS;Yus MC;Esteban EA;Guedea MP;Botaya RM;
Primary prevention of anxiety disorders in primary care: A systematic review
Prev Med.2014;():-. FI: 2,932 Q1

• Notario-Pacheco B;Martinez-Vizcaino V;Trillo-Calvo E;Perez-Yus MC;Serrano-Parra D;Garcia-Campayo J;
Validity and reliability of the Spanish version of the 10-item CD-RISC in patients with fibromyalgia
Health and Quality of Life Outcomes.2014;12():-. FI: 2,099 Q2

• Garcia-Campayo J;Navarro-Gil M;Andres E;Montero-Marin J;Lopez-Artal L;Demarzo MMP;
Validation of the Spanish versions of the long (26 items) and short (12 items) forms of the Self-Compassion Scale (SCS)
Health and Quality of Life Outcomes.2014;12():-. FI: 2,099 Q2

• Esteva M;Ruiz A;Ramos M;Casamitjana M;Sanchez-Calavera MA;Gonzalez-Lujan L;Pita-Fernandez S;Leiva A;Pertega-Diaz S;Costa-Alcaraz AM;Macia F;Espi A;Segura JM;Lafita S;Novella MT;Yus C;Olivan B;Cabeza E;Seoane-Pillado T;Lopez-Calvino B;Llobera J;
Age differences in presentation, diagnosis pathway and management of colorectal cancer
Cancer Epidemiology.2014;38(4):346-353. FI: 2,558 Q2

• Montero-Marin J;Demarzo MMP;Pereira JP;Olea M;Garcia-Campayo J;
Reassessment of the Psychometric Characteristics and Factor Structure of the ‘Perceived Stress Questionnaire’ (PSQ): Analysis in a Sample of Dental Students
Plos One.2014;9(1):-. FI: 3,534 Q1

• Soler J;Franquesa A;Feliu-Soler A;Cebolla A;Garcia-Campayo J;Tejedor R;Demarzo M;Banos R;Pascual JC;Portella MJ;
Assessing decentering: validation, psychometric properties, and clinical usefulness of the Experiences Questionnaire in a Spanish sample
Behav Ther.2014;45(6):863-871. FI: 3,099 Q1

• Moreno-Peral P;Conejo-Ceron S;Motrico E;Rodriguez-Morejon A;Fernandez A;Garcia-Campayo J;Roca M;Serrano-Blanco A;Rubio-Valera M;Bellon JA;
Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: A systematic review of cohort studies
Journal of Affective Disorders.2014;168():337-348. FI: 3,705 Q1

• Luciano JV;Barrada JR;Aguado J;Osma J;Garcia-Campayo J;
Bifactor analysis and construct validity of the HADS: a cross-sectional and longitudinal study in fibromyalgia patients
Psychol Assess.2014;26(2):395-406. FI: 2,84 Q1

• Fayed N;Andres E;Viguera L;Modrego PJ;Garcia-Campayo J;
Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain
Acad Radiol.2014;21(9):1211-1217. FI: 2,077 Q2

• Escolano C;Navarro-Gil M;Garcia-Campayo J;Congedo M;Minguez J;
The effects of individual upper alpha neurofeedback in ADHD: an open-label pilot study
Appl Psychophysiol Biofeedback.2014;39(42097):193-202. FI: 1,593 Q3

• Quezada-Berumen LD;Gonzalez-Ramirez MT;Cebolla A;Soler J;Garcia-Campayo J;
Body awareness and mindfulness: Validation of the Spanish version of the Scale of Body Connection
Actas Espanolas de Psiquiatria.2014;42(2):57-67. FI: 0,759 Q4

• Escolano C;Navarro-Gil M;Garcia-Campayo J;Congedo M;De RD;Minguez J;
A controlled study on the cognitive effect of alpha neurofeedback training in patients with major depressive disorder
Front Behav Neurosci.2014;8():296-. FI: 4,16 Q1

• Demarzo MM;Montero-Marin J;Stein PK;Cebolla A;Provinciale JG;Garcia-Campayo J;
Mindfulness may both moderate and mediate the effect of physical fitness on cardiovascular responses to stress: a speculative hypothesis
Front Physiol.2014;5():105-. FI:

• Montero-Marin J;Prado-Abril J;Demarzo MMP;Gascon S;Garcia-Campayo J;
Coping with Stress and Types of Burnout: Explanatory Power of Different Coping Strategies
Plos One.2014;9(2):-. FI: 3,534 Q1

• Montero-Marin J;Piva Demarzo MM;Stapinski L;Gili M;Garcia-Campayo J;
Perceived stress latent factors and the burnout subtypes: a structural model in dental students
PLoS One.2014;9(6):-. FI: 3,534 Q1

• Soler J;Cebolla A;Feliu-Soler A;Demarzo MM;Pascual JC;Banos R;Garcia-Campayo J;
Relationship between meditative practice and self-reported mindfulness: the MINDSENS composite index
PLoS One.2014;9(1):-. FI: 3,534 Q1

• Tran US;Cebolla A;Gluck TM;Soler J;Garcia-Campayo J;von MT;
The serenity of the meditating mind: a cross-cultural psychometric study on a two-factor higher order structure of mindfulness, its effects, and mechanisms related to mental health among experienced meditators
PLoS One.2014;9(10):-. FI: 3,534 Q1

• Luciano JV;Guallar JA;Aguado J;Lopez-Del-Hoyo Y;Olivan B;Magallon R;Alda M;Serrano-Blanco A;Gili M;Garcia-Campayo J;
Effectiveness of group acceptance and commitment therapy for fibromyalgia: A 6-month randomized controlled trial (EFFIGACT study)
Pain.2014;155(4):693-702 FI:5,836 Q1D1

• Olivan-Blazquez B;Herrera-Mercadal P;Puebla-Guedea M;Perez-Yus MC;Andres E;Fayed N;Lopez-Del-Hoyo Y;Magallon R;Roca M;Garcia-Campayo J;
Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up
Pain.2014;155(12):2517-2525 FI:5,836 Q1D1

• Fayed N;Olivan-Blazquez B;Herrera-Mercadal P;Puebla-Guedea M;Perez-Yus MC;Andres E;Del Hoyo YL;Magallon R;Viguera L;Garcia-Campayo J;
Changes in Metabolites after Treatment with Memantine in Fibromyalgia. A Double-Blind Randomized Controlled Trial with Magnetic Resonance Spectroscopy with a 6-month Follow-up
Cns Neuroscience & Therapeutics.2014;20(11):999-1007 FI:3,784Q1

• Navarro J;del Moral R;Alonso MF;Loste P;Garcia-Campayo J;Lahoz-Beltra R;Marijuan PC;
Validation of laughter for diagnosis and evaluation of depression
Journal of Affective Disorders.2014;160():43-49. FI: 3,705 Q1

• Serrano MJ;Vives M;Mateu C;Vicens C;Molina R;Puebla-Guedea M;Gili M;
Therapeutic adherence in primary care depressed patients: a longitudinal study
Actas Espanolas de Psiquiatria.2014;42(3):91-98. FI: 0,759

• Luciano JV, D’Amico F, Cerdà-Lafont M, Peñarrubia-María MT, Knapp M,Cuesta-Vargas AI, Serrano-Blanco A, García-Campayo JCost-utility of cognitivebehavioral therapy versus U.S. Food and Drug Administration recommended drugs andusual care in the treatment of patients with fibromyalgia: an economic evaluationalongside a 6-month randomized controlled trial
Arthritis Res Ther.2014;16(5):451. FI: 4,117 Q1

• Escolano C, Navarro-Gil M, Garcia-Campayo J, Minguez J
The effects of asingle session of upper alpha neurofeedback for cognitive enhancement: asham-controlled study
Appl Psychophysiol Biofeedback.2014;39:227-236. FI: 1,593 Q3

• Moreno-Peral P, Luna Jde D, Marston L, King M, Nazareth I, Motrico E,GildeGómez-Barragán MJ, Torres-González F, Montón-Franco C, Sánchez-Celaya M,Díaz-Barreiros MÁ, Vicens C, Muñoz-Bravo C, Bellón JÁ
Predicting the onset ofanxiety syndromes at 12 months in primary care attendees. The predictA-Spainstudy
PLoS One.2014;9(9):-. FI: 3,534 Q1

• Qureshi A, Garcia Campayo J, Eiroa-Orosa FJ, Sobradiel N, Collazos F, Febrel Bordejé M, Roncero C, Andrés E, Casas M
Epidemiology of substance abuse amongmigrants compared to native born population in primary care
Am J Addict.2014;23(4):337-342. FI:1,52 Q2

• Garcia-Toro M, Gili M, Ibarra O, Monzón S, Vives M, Garcia-Campayo J,Gomez-Juanes R, Roca M
Metabolic syndrome improvement in depression six monthsafter prescribing simple hygienic-dietary recommendations
BMC Res Notes.2014;7():339-. FI:

• Buitrago Ramírez F, Ciurana Misol R, Chocrón Bentata L, Fernández Alonso MdelC, García Campayo J, Montón Franco C, Tizón García JL, Herrero Velázquez S
Recomendaciones para la prevención de los trastornos de la salud mental en atención primaria
Aten Primaria.2014;46(4):59-74 FI:0,894 Q3

• Gili M, García Campayo J, Roca M
Economic crisis and mental health. SESPAS report 2014
Gac Sanit.2014;28(1):104-108 FI:1,25 Q3

• Bellón JÁ, Moreno-Peral P, Moreno-Küstner B, Motrico E, Aiarzagüena JM,Fernández A, Fernández-Alonso C, Montón-Franco C, Rodríguez-Bayón A,Ballesta-Rodríguez MI, Runte-Geidel A, Payo-Gordón J, Serrano-Blanco A,Oliván-Blázquez B, Araujo L, Muñoz-García Mdel M, King M, Nazareth I, Amezcua M
Patients’ opinions about knowing their risk for depression and what to do aboutit. The predictD-qualitative study
PLoS One.2014;9(3). FI: 3,534 Q1

• Garcia-Campayo J, Cebolla A, Baños RM
Eating disorders and primary care:the challenge of new technologies
Aten Primaria.2014;46(5):229-230. FI:0,894 Q3

• Demarzo MM, Andreoni S, Sanches N, Perez S, Fortes S, Garcia-Campayo J
Mindfulness-based stress reduction (MBSR) in perceived stress and quality oflife: an open, uncontrolled study in a Brazilian healthy sample
Explore (NY).2014;10(2):118-120 FI:0,935 Q3

• Ibarra O, Gili M, Roca M, Vives M, Serrano MJ, Pareja A, García-Campayo J,Gómez-Juanes R, García-Toro M
The Mediterranean diet and micronutrient levels indepressive patients
Nutr Hosp.2014;31(3):1171-1175. FI: 1,25 Q4

• Proyecto FIS: Eficacia y coste-efectividad de tres intervenciones psicológicas de baja intensidad aplicadas por medio de TICs para el tratamiento de la depresión en Atención Primaria: un estudio controlado (PI13/01637) IP: García Campayo, José Javier
• Proyecto competitivo Ministerio de Sanidad: Evaluacion de la eficacia de memantina en el tratamiento de la fibromialgia: ensayo clínico aleatorizado doble ciego. (EUDRACT2011-006244-73) IP: García Campayo, José Javier

• Grupo Consolidado de investigación aplicada de la DGA “Grupo Aragonés de Investigación en Atención Primaria (GAIAP
• Javier García Campayo:
o Investigador principal del grupo RD 06/0018/0020 perteneciente a la Red de Investigación en Actividades Preventivas y Promoción de la Salud en Atención Primaria (REDIAPP)